Little or no July effect in neurosurgery

December 15, 2015

CHARLOTTESVILLE, VA (DEC. 15, 2015). Researchers have found little or no 'July effect' in the field of neurosurgery.

The 'July effect' is the theory that more medical and surgical errors, and, consequently, greater levels of morbidity and mortality occur during July, the month during which fourth year medical students become interns and residents advance to higher levels of training where they face greater challenges and more responsibility.

There is debate as to whether the July effect exists in neurosurgery and, if so, to what extent. Some studies have found that it may apply to specific disorders or groups of patients, and others that it doesn't appear to exist at all. To obtain a more comprehensive answer, researchers from Columbia University, New York University, and the University of Pittsburgh decided to test whether the July effect exists in adult patients treated by neurosurgeons. The findings are published in the article 'Assessment of the 'July Effect': outcomes after early resident transition in adult neurosurgery,' by Bryan A. Lieber, MD, and colleagues, published today online, ahead of print, in the Journal of Neurosurgery.

The authors examined data from neurosurgical cases, managed between 2006 and 2012, in which information on resident participation was included. These included 16,343 cases managed in academic medical centers, where residents were part of the surgical team, and 20,792 cases managed at community-based hospitals, where no residents were involved. The data were obtained from one of the largest prospective medical databases -- the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database -- which contains data on 30-day morbidity and mortality as well as a wide variety of other postoperative outcomes. The authors focused on adult neurosurgery as a whole as well as on four neurosurgical patient populations: those undergoing spine surgery, cranial surgery, open vascular surgery, and subarachnoid hemorrhage.

The 12-month academic training year was broken down into four quarters, and data on neurosurgical patients who were treated during the first quarter (Q1: July through September) were compared with data on neurosurgical patients treated during the fourth quarter (Q4: April through June) to assess whether there were significant differences in postoperative complications or deaths between the two time periods. Quarters were used because the ACS NSQIP database does not provide monthly totals. Q1 is the period in which interns and residents begin to take on new challenges and responsibilities; it is during this period that a July effect, if present, would be found. By Q4, interns and residents have spent most of the year dealing with and learning from these challenges and responsibilities, and will soon advance to a higher level of training. Different levels of surgical training were examined: intern (post-graduate year [PGY] 1); junior resident (PGY 2 through 4); senior or chief resident (PGY 5 through 7); and fellow (training that goes beyond residency).

The authors looked at postoperative patient mortality and morbidity (complications) during the 30-day period following surgery. Complications were broken down into medical complications (such as pneumonia, stroke, and deep venous thrombosis) and surgical complications (such as surgical site infections and bleeding that required transfusion); they were also broken down into mild complications (such as superficial wound infections) and severe complications (such as strokes and heart attacks). In addition, the authors examined factors related to efficiency, such as the duration of surgery and length of the entire hospital stay.

In general, the overall results showed no significant differences in neurosurgical patient outcomes in academic medical centers between Q1 and Q4 with respect to mortality, medical complications, or mild complications. The authors report no clear evidence for decreased efficiency during Q1, as compared with Q4.

The authors looked at postoperative mortality and complications among neurosurgical patients treated at community-based hospitals for the same yearly quarters. They found no significant differences in mortality or complications between Q1 and Q4.

When the four neurosurgical patient populations were examined, the authors found no significant differences in mortality or morbidity between Q1 and Q4. When the various levels of neurosurgical training were stratified, the authors found no significant differences between Q1 and Q4 with respect to patient mortality, medical complications, or mild complications. However, they did find an increase in the rate of surgical complications during Q1 for cases involving junior resident participation (8.7% vs. 6.9% in Q4, p = 0.04), which they attribute to a modest (1.58%) increase in transfusions, and an increase in the rate of repeated operations (2.19% vs. 1.73% in Q4, p < 0.001) observed for cases involving senior resident participation. These increases were not large, although they were statistically significant.

Based on their own clinical experiences, the authors note that the July transition period is 'fraught with clinical challenges.' Nevertheless, they state that overall their findings show "no clear evidence for an increase in rates of morbidity or mortality during this transition period" (Q1). In fact, they continue, "if there is a July Effect, the effect size is probably too small to detect." Based on the results of this study, the researchers infer that neurosurgery as a field has been successful in guiding trainees during this critical and challenging period.

"With the emphasis on quality of care in current U.S. healthcare reform, our findings are reassuring," says the corresponding author, Blake E. S. Taylor, a Columbia University medical student, "as it appears that neurosurgical training programs are providing residents with excellent clinical and surgical education without compromising patient care."
-end-
Lieber BA, Appelboom G, Taylor BES, Malone H, Agarwal N, Connolly

ES Jr. Assessment of the 'July Effect': outcomes after early resident transition in adult neurosurgery. Journal of Neurosurgery, published online, ahead of print, Dec. 15, 2015; DOI: 10.3171/2015.4.JNS142149.

Disclosures: No funding or support was provided for this study.

For additional information, please contact:

Ms. Jo Ann M. Eliason
Communications Manager
Journal of Neurosurgery Publishing Group
One Morton Drive, Suite 200, Charlottesville, VA 22903
jaeliason@thejns.org
Phone 434-982-1209
Fax 434-924-2702

For 71 years, the Journal of Neurosurgery has been recognized by neurosurgeons and other medical specialists the world over for its authoritative clinical articles, cutting-edge laboratory research papers, renowned case reports, expert technical notes, and more. Each article is rigorously peer reviewed. The Journal of Neurosurgery is published monthly by the JNS Publishing Group, the scholarly journal division of the American Association of Neurological Surgeons. Other peer-reviewed journals published by the JNS Publishing Group each month include Neurosurgical Focus, the Journal of Neurosurgery: Spine, and the Journal of Neurosurgery: Pediatrics. All four journals can be accessed at http://www.thejns.org.

Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 8,300 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. All active members of the AANS are certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons (Neurosurgery) of Canada or the Mexican Council of Neurological Surgery, AC. Neurological surgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the entire nervous system including the brain, spinal column, spinal cord, and peripheral nerves. For more information, visit http://www.AANS.org.

Journal of Neurosurgery Publishing Group

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.